Quanterix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Quanterix and other ETFs, options, and stocks.

About QTRX

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. 

CEO
Everett V. Cunningham
CEOEverett V. Cunningham
Employees
450
Employees450
Headquarters
Billerica, Massachusetts
HeadquartersBillerica, Massachusetts
Founded
2007
Founded2007
Employees
450
Employees450

QTRX Key Statistics

Market cap
248.31M
Market cap248.31M
Price-Earnings ratio
-2.10
Price-Earnings ratio-2.10
Dividend yield
Dividend yield
Average volume
827.19K
Average volume827.19K
High today
$5.73
High today$5.73
Low today
$5.12
Low today$5.12
Open price
$5.71
Open price$5.71
Volume
987.05K
Volume987.05K
52 Week high
$8.77
52 Week high$8.77
52 Week low
$4.05
52 Week low$4.05

Stock Snapshot

With a market cap of 248.31M, Quanterix(QTRX) trades at $5.29. The stock has a price-to-earnings ratio of -2.10.

During the trading session on 2026-03-05, Quanterix(QTRX) shares reached a daily high of $5.73 and a low of $5.12. At a current price of $5.29, the stock is +3.4% higher than the low and still -7.7% under the high.

Trading volume for Quanterix(QTRX) stock has reached 987.05K, versus its average volume of 827.19K.

The stock's 52-week range extends from a low of $4.05 to a high of $8.77.

The stock's 52-week range extends from a low of $4.05 to a high of $8.77.

QTRX News

TipRanks 2d
Quanterix: Encouraging Q4 Beat but Fragile Recovery and Limited Visibility Keep Rating at Hold

TD Cowen analyst Daniel Brennan maintained a Hold rating on Quanterix yesterday and set a price target of $7.00. Daniel Brennan has given his Hold rating due t...

TipRanks 2d
Quanterix Faces Significant Supply Chain Risk From Single-Source Instrument Manufacturers

Quanterix (QTRX) has disclosed a new risk, in the Supply Chain category. Quanterix remains exposed to concentration risk because it depends on single-source co...

The Motley Fool 2d
Quanterix Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. March 2, 2026 Call participants President and Chief Executive Officer — Everett Cunningham Chief Financial Officer — Vandana Sri...

Quanterix Q4 2025 Earnings Call Transcript

More QTRX News

Nasdaq 3d
Quanterix Corporation Reports Q4 Loss, Beats Revenue Estimates

Quanterix Corporation (QTRX) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss o...

Quanterix Corporation Reports Q4 Loss, Beats Revenue Estimates
TipRanks 3d
Quanterix reports Q4 EPS (49c) vs. (30c) last year

Reports Q4 revenue $43.9M, consensus $38.0M. “I am thrilled to be joining Quanterix (QTRX) at a time when the company is well-positioned to deliver long-term gr...

TipRanks 3d
Quanterix sees FY26 revenue $169M-$174M, consensus $168.8M

Quanterix (QTRX) is issuing its initial guidance for 2026. The Company expects revenues of $169 to $174 million, GAAP gross margin of 45-49%, and adjusted gross...

People also own

Based on the portfolios of people who own QTRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.